Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glycobiology of theLeishmaniaparasite and emerging targets for antileishmanial drug discovery

11 Jun 2010

Abstract excerpt

IMPORTANCE OF THE FIELD: Parasitic diseases that pose a threat to human life include leishmaniasis - caused by protozoa of Leishmania species. Existing drugs have limitations due to deleterious side effects like teratogenicity and factors like cost and drug resistance, thus furthering the need to develop this area of research. AREAS COVERED IN THIS REVIEW: We came across drug targets, very recently characterised,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carbohydrate Chemistry and Synthesis
Share to Research on Leishmaniasis Studies
Share to Trypanosoma species research and implications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20536412
DOI: 10.1517/14728222.2010.495125

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glycobiology of theLeishmaniaparasite and emerging targets for antileishmanial drug discoveryPMID 20536412Read ↗

Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug CandidatesSemantic proximity Read ↗

Emerging therapeutic targets for treatment of leishmaniasisSemantic proximity Read ↗

Unveiling the Sugary Secrets of Plasmodium ParasitesSemantic proximity Read ↗

An overview of biochemically characterized drug targets in metabolic pathways of Leishmania parasiteSemantic proximity Read ↗

Targeting the GPI biosynthetic pathwaySemantic proximity Read ↗

Potential therapeutic targets and the role of technology in developing novel antileishmanial drugs.Semantic proximity Read ↗

UnderstandingLeishmaniaparasites through proteomics and implications for the clinicSemantic proximity Read ↗

Parasite Glycobiology: A Bittersweet SymphonySemantic proximity Read ↗

Novel antimalarial drug targets: hope for new antimalarial drugsSemantic proximity Read ↗

Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future ProspectsSemantic proximity Read ↗

Network-Based Approaches Reveal Potential Therapeutic Targets for Host-Directed Antileishmanial Therapy Driving Drug RepurposingSemantic proximity Read ↗

In silico Metabolic Pathway Analysis Identifying Target Against Leishmaniasis – A Kinetic Modeling ApproachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.